Share-based Payment Arrangement, Expense of Vivani Medical, Inc. from 30 Jun 2015 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Vivani Medical, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2015 to 30 Sep 2025.
  • Vivani Medical, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $276,000, a 42% decline year-over-year.
  • Vivani Medical, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $1,419,000, a 15% decline year-over-year.
  • Vivani Medical, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $1,610,000, a 14% decline from 2023.
  • Vivani Medical, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1,864,000, a 44% increase from 2022.
  • Vivani Medical, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1,296,000, a 22% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Vivani Medical, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,419,000 $276,000 -$196,000 -42% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $1,615,000 $391,000 +$8,000 +2.1% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $1,607,000 $350,000 -$3,000 -0.85% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $1,610,000 $402,000 -$58,000 -13% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 $1,668,000 $472,000 -$39,000 -7.6% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $1,707,000 $383,000 -$141,000 -27% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 $1,848,000 $353,000 -$16,000 -4.3% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 $1,864,000 $460,000 +$289,000 +169% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $1,575,000 $511,000 +$120,000 +31% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $1,455,000 $524,000 +$130,000 +33% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $1,325,000 $369,000 +$29,000 +8.5% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q4 2022 $1,296,000 $171,000 -$1,069,000 -86% 01 Oct 2022 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q3 2022 $2,365,000 $391,000 +$1,000 +0.26% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $2,364,000 $394,000 +$375,000 +1974% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $1,989,000 $340,000 +$321,000 +1689% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $1,668,000 $1,240,000 +$1,213,000 +4493% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $455,000 $390,000 +$363,000 +1344% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $92,000 $19,000 -$69,000 -78% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022 2022 Q2
Q1 2021 $161,000 $19,000 -$260,000 -93% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q4 2020 $421,000 $27,000 -$455,000 -94% 01 Oct 2020 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q3 2020 $876,000 $27,000 -$659,000 -96% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $1,535,000 $88,000 -$771,000 -90% 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021 2021 Q2
Q1 2020 $2,306,000 $279,000 -$619,000 -69% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $2,925,000 $482,000 -$318,000 -40% 01 Oct 2019 31 Dec 2019 10-K 16 Mar 2021 2020 FY
Q3 2019 $3,243,000 $686,000 -$191,000 -22% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 $3,434,000 $859,000 +$232,000 +37% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020 2020 Q2
Q1 2019 $3,202,000 $898,000 -$387,000 -30% 01 Jan 2019 31 Mar 2019 10-Q 26 Jun 2020 2020 Q1
Q4 2018 $3,589,000 $800,000 -$163,000 -17% 01 Oct 2018 31 Dec 2018 10-K 19 Mar 2020 2019 FY
Q3 2018 $3,752,000 $877,000 -$28,000 -3.1% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2019 Q3
Q2 2018 $3,780,000 $627,000 -$308,000 -33% 01 Apr 2018 30 Jun 2018 10-Q 06 Aug 2019 2019 Q2
Q1 2018 $4,088,000 $1,285,000 +$304,000 +31% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
Q4 2017 $3,784,000 $963,000 +$176,000 +22% 01 Oct 2017 31 Dec 2017 10-K 19 Mar 2019 2018 FY
Q3 2017 $3,608,000 $905,000 +$7,000 +0.78% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018 2018 Q3
Q2 2017 $3,601,000 $935,000 +$199,000 +27% 01 Apr 2017 30 Jun 2017 10-Q 07 Aug 2018 2018 Q2
Q1 2017 $3,402,000 $981,000 +$35,000 +3.7% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q4 2016 $3,367,000 $787,000 01 Oct 2016 31 Dec 2016 10-K 19 Mar 2019 2018 FY
Q3 2016 $898,000 +$42,000 +4.9% 01 Jul 2016 30 Sep 2016 10-Q 06 Nov 2017 2017 Q3
Q2 2016 $736,000 +$172,000 +30% 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017 2017 Q2
Q1 2016 $946,000 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q3 2015 $856,000 01 Jul 2015 30 Sep 2015 10-Q 04 Nov 2016 2016 Q3
Q2 2015 $564,000 01 Apr 2015 30 Jun 2015 10-Q 08 Aug 2016 2016 Q2

Vivani Medical, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,610,000 -$254,000 -14% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $1,864,000 +$568,000 +44% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $1,296,000 -$372,000 -22% 01 Jan 2022 31 Dec 2022 10-K 26 Mar 2024 2023 FY
2021 $1,668,000 +$1,247,000 +296% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $421,000 -$2,504,000 -86% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2022 2021 FY
2019 $2,925,000 -$664,000 -19% 01 Jan 2019 31 Dec 2019 10-K 16 Mar 2021 2020 FY
2018 $3,589,000 -$195,000 -5.2% 01 Jan 2018 31 Dec 2018 10-K 19 Mar 2020 2019 FY
2017 $3,784,000 +$417,000 +12% 01 Jan 2017 31 Dec 2017 10-K 19 Mar 2019 2018 FY
2016 $3,367,000 01 Jan 2016 31 Dec 2016 10-K 19 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.